Table 2 Peak expiratory flow (PEF) & forced expiratory volume in 1 second (FEV 1 ) in patients receiving montelukast vs. placebo
Montelukast | Placebo | p value | |||
|---|---|---|---|---|---|
n | Mean (±SD) | n | Mean (±SD) | ||
PEF at admission | 50 | 123.82 (±48.76) | 50 | 144.70 (±78.85) | 0.11 |
PEF at day 2 | 50 | 149.48 ± 75.76 | 50 | 173.41 ± 103 | 0.20 |
PEF at day3 | 50 | 164.50 ±82.74 | 50 | 183.35 ± 113.12 | 0.47 |
PEF at discharge | 50 | 160.12 (±77.00) | 50 | 187.08 (±108.93) | 0.15 |
FEV1 at admission | 50 | 0.82 (±0.35) | 50 | 0.90 (±0.60) | 0.46 |
FEV1 at discharge | 50 | 1.07 (±0.54) | 50 | 1.21 (±0.68) | 0.29 |